A detailed history of Alphabet Inc. transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 448,492 shares of RANI stock, worth $932,863. This represents 0.07% of its overall portfolio holdings.

Number of Shares
448,492
Previous 448,492 -0.0%
Holding current value
$932,863
Previous $1.7 Million 43.19%
% of portfolio
0.07%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$5.07 - $6.89 $312,494 - $424,672
-61,636 Reduced 12.08%
448,492 $2.31 Million
Q4 2022

Feb 13, 2023

SELL
$5.51 - $10.02 $1.13 Million - $2.05 Million
-204,343 Reduced 28.6%
510,128 $3.01 Million
Q1 2022

Nov 14, 2022

BUY
$12.21 - $23.14 $8.72 Million - $16.5 Million
714,471 New
714,471 $9.65 Million

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $50.9M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.